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INTRODUCTION:  Pancreas  angiosarcoma  is a very  aggressive  malignant  neoplasm.  The  symptoms  are
nonspecific  and  it is  usually  diagnosed  at an  advanced  stage,  which  confers  a poor  prognosis.
PRESENTATION  OF  CASE:  We  present  a 56-year-old  woman  with  abdominal  epigastric  pain  and  nausea.
The abdominal  CT-scan  showed  a 7 cm mass  within  the  head  of the pancreas  and  the pathology  and
immunochemistry  analysis  were  positive  for  pancreas  angiosarcoma.  Intra-operatively  the  tumor  was
irresectable.
DISCUSSION:  Pancreas  angiosarcoma  is an extremely  rare neoplasm  with  non-specific  diagnosis.  ThePancreas angiosarcoma
Abdominal pain
Irresectable tumor
histology  has  a wide  range  of presentations  and immunohistochemistry  is  required.  The  surgery  appears
to  be  the only  effective  treatment.
CONCLUSION:  We  report  the  seventh  case  of pancreas  angiosarcoma  in  the  English  literature.  Despite  it’s
irresectability,  the  patient  was  asymptomatic  two  months  after  surgery,  initiating  chemotherapy  with
paclitaxel,  with  good  tolerance.
© 2020  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.  This  is an  open




















Angiosarcomas are highly malignant endothelial-cell tumors of
vascular or lymphatic origin [1,2], representing less than 2% of
all soft tissue sarcomas [3]. Angiosarcomas of the pancreas are
extremely rare, with only six cases reported in the literature [4,5].
They are fast growing and very aggressive tumors with a poor prog-
nosis [6,6]. Since the symptoms are nonspecific, they are usually
diagnosed at an advanced stage [7]. Surgery appears to be the only
effective treatment approach in localized disease [4,6]. We  report
the seventh case of pancreas angiosarcoma in the English literature.
This work is reported in line with SCARE 2018 criteria [8].
2. Presentation of case
A 56-year-old woman was admitted in our hospital with two
months history of abdominal epigastric pain and nausea. She was
a housewife with no known exposure to carcinogens and drugs
and with no relevant family and psychosocial history. Her medical
and surgical history was unremarkable, except for appendicec-
tomy and tubal ligation decades before. Laboratory tests showed
∗ Corresponding author at: Departamento de Cirurgia Geral, Hospital de Santa
Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz
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creativecommons.org/licenses/by-nc-nd/4.0/). diminished haemoglobin level (11 g/dL), CEA 1,8 ng/mL (Refer-
nce range: < 5), CA 19.9 8,9 U/mL (RR: 0–37), chromogranin A
1,7 ng/mL (RR: <102) and NSE 10,9 ug/L (RR: 0–16,3). A contrast
nhanced CT-scan (Fig. 1) revealed a 7 cm mass within the head
f the pancreas with no apparent vascular or surrounding organ
nvasion. There was  no distant spread location. Pancreatic biopsy
hrough ultrasound was  performed and demonstrated atypical and
leomorphic malignant endothelial cells, that are the hallmark
f angiosarcoma. Kocher laparotomy, revealed an 9 × 9 cm head
ancreatic mass, with superior mesenteric artery invasion and
ompression of the third portion of duodenum, thus revealing itself
ntra-operatively irresectable. A new biopsy was done and a gastro-
ejunostomy with Braun’s jejunojejunostomy was performed by a
eneral surgery with 20 years of experience in hepatobiliopancre-
tic surgery. The histological examination of the pancreatic biopsy
Fig. 2) showed a solid pattern neoplasm consisting of spindle
nd epithelioid cells, richly vascularized with moderate to intense
uclear pleomorphism and the presence of atypical endothelial
ells. Immunohistochemical studies (Fig. 3) demonstrated positive
taining for vimentin and endothelial markers CD34, CD31, factor
III and Fli-1, but negativity for AE1/AE3, SMA, desmin, DOG-1,
D117 and pS100, thus establishing the diagnosis of pancreatic
ngiosarcoma.The patient was  discharged on postoperative day 4 with no
omplications. Based on multidisciplinary discussion, she was pro-
osed for palliative chemotherapy with paclitaxel beginning on
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Fig. 2. Biopsy specimen showing pancreatic tissue with a solid, vessel-rich
day 26 after surgery. The patient understood and adhered fully
to the treatment plan. At two months after surgery she maintains
chemotherapy and has no tumor-related symptoms.
3. Discussion
Angiosarcomas represent vascular neoplasms with a very low
incidence, even within sarcomas [9]. A pancreatic primary origin is
especially rare, with the present case being the seventh accounted
in the English literature. Table 1 summarizes the most impor-
tant features of the primary pancreatic angiosarcomas published
to date. More common origins of angiosarcomas are the head, neck
and breast. In the abdominal compartment, angiosarcomas develop
mostly in the liver and the spleen [1]. Regarding of the low number
of cases worldwide, this is still a rather unknown entity. However,





117rn and high grade mesenchimatous neoplastic cells (HE x50 and HE x400).
thorium dioxide and vinyl chloride), chronic lymphedema and
ome hereditary syndromes [10].
The histology findings are non-specific, with a wide range of
istological appearances, often mimicking carcinomas, especially
hen showing epithelioid-cell morphology. Therefore, immuno-
istochemical staining is mandatory. Positive staining for vascular
arkers, which include CD31, CD34, Factor-VIII, Ulex europaeus
gglutinin 1 (UEA-1), Friend leukemia integration 1 (Fli-1),
ndothelin-1, vascular endothelial growth factor receptor (VEGFR)
nd von-Willebrand factor (vWF), is typical. CD31, vWF  and UEA-
 are believed to be positive in less differentiated tumors. The
xpression of epithelial markers, such as low-molecular weight
ytokeratins or the epithelial membrane antigen (EMA) may  be
ound both in angiosarcomas and carcinomas and is thereby
nhelpful in their distinction. Lymphoid markers (CD45 or CD30)







































Review of reported cases of literature.
Article Age Sex Symptoms Laboratory CT scan Surgery Histology Immunohistochemical
profile
Follow-up






















Maeyashiki et al. [3] 72 Man Dizziness and
black stools











































dead at day 5
postoperative































Worth  et al. [7] 78 Woman Swollen
inguinal
lymph nodes
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We would like to acknowledge Professor Luis Costa (director of
Oncology Department at Hospital de Santa Maria and Professor of
Medicine at the University of Lisbon), Andreia Barão, Teresa Pereira,Fig. 3. Immunohistochemical staining, with positi
Unlike the majority of the cases reported so far, which had a
severe clinical presentation, ours was discovered only with mild
abdominal pain. In this case, the resection of the tumor proved
to be impossible intra-operatively, because of superior mesenteric
artery invasion. Due to the strong duodenal adhesion and proba-
ble invasion, a gastrojejunostomy was performed. The alternative
therapeutic options (chemo- and radiotherapy) have shown poor
results in this type of neoplasms. Surgery remains the only known
curative treatment. However, given the lack of success of the per-
formed surgery, paclitaxel-based chemotherapy was  proposed in a
disciplinary discussion, since this agent seems to have a relevant
activity against angiosarcomas of other origins [11].
At the date of submission of this article, four months after the
diagnosis, no signs or symptoms of tumor expansion or metastasis
have shown up, and no complications of chemotherapy have been
reported.
4. Conclusion
Pancreatic angiosarcoma is a very rare entity. Consequently, lit-
tle is known about risk factors, tumor behavior and efficacy of the
therapeutic options available. Imaging features are non-specific,
with the diagnosis being only established through histology and
immunohistochemistry analysis. The prognosis is dismal, espe-
cially when symptoms are already present. Surgical resection
seems to be the only curative option, with radio- and chemotherapy
being palliative alternatives.
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